We have partnerships with several companies that provide useful diagnostic tools in the assessment & management of Arterial Health. These devices measure Endothelial Function, Arterial Stiffness (Atherosclerotic Burden), Ankle-Brachial Index (ABI), Segmental Limb Studies and risk assessment analysis.
Endothelial Function testing is a vital tools for clinicians to assess the progression and management of atherosclerosis. This tools is helpful as atherosclerosis is proven to lead to the development of Coronary Artery Disease.
Arterial Stiffness or ‘Atherosclerotic Burden’ is used determine the performance of your arteries for patients with suspected or existing vascular disease. Arterial Stiffness is useful for physicians in the management of Coronary Artery Disease and Peripheral Vascular Disease.
Ankle Brachial Index (ABI)
Ankle Brachial Index is a simple test to assess the existence and location of blockages in the peripherial artery region (legs) of the body. ABI and Segmental Limb Studies are useful in managing Peripheral Vascular Disease.
Risk Assessment Analysis
These devices offers a unique risk assessment analysis that combines the Framingham Stratification Analysis as well as other factors to compare your results with an outcomes database to determine patient risk. This risk assessment is proven to be greater than 90% predictive accuracy.
Cost & Revenue Analysis
The Arterial Function Assessment devices remain a sound investments in non-invasive Cardiology. They offer various clinical tools and a substantial revenue component needed in today’s healthcare environment. The reimbursement in the U.S for these diagnostic studies can total $400 – $500 total per patient.